腎臓病市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00014589
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 215
Buy Now

腎臓病市場は、2019 年の 811 億 2,811 万米ドルから、2027 年までに 1,334 億 4,471 万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 6.5% の CAGR で成長すると推定されています。

  ;

政策立案者は、医薬品および医療への公平かつ手頃な価格で持続可能なアクセスを実現するために、医薬品政策オプションの適切な組み合わせが確実に実施されるようにする必要があります。世界保健機関は、重要な医薬品リストの概念やユニバーサル・ヘルス・カバレッジ(UHC)アプローチなど、政策立案者が適切な政策を策定できるよう支援するためのさまざまな戦略を計画しています。さらに、先進的な UHC および社会的保護制度を備えたヨーロッパ諸国は、国民にさまざまな重要な医薬品を無料または低コストで提供することを目的とした医薬品価格設定および償還システムを開発しました。たとえば、アルメニアは、結核、精神疾患、糖尿病、慢性腎不全などの特定の病気の薬の100%償還を保証しています。

2019 年 5 月、血中のカリウム濃度が高い (高カリウム血症) の治療に使用される処方薬 VELTASSA が、AMNOG プロセスの完了後、ドイツで償還を確保しました。 (価格交渉と仲裁プロセス)。さらに、フィンランド、オーストリア、ポルトガル、スペイン、ベルギーでもこの薬の償還が確保され、英国の国立医療評価研究所から好意的な推奨を受けました。さらに、2019年末にはスウェーデン、ノルウェー、デンマーク、ベルギー、ドイツ、スペイン、オランダ、オーストリアでもVELTASSAを発売しました。さらに、2018年にVifor Pharmaは、日本におけるVELTASSAの規制および償還承認のプロセスを促進するために、ゼリア新薬株式会社とのライセンス契約を発表しました。さらに、2019年12月、中国国家医療安全局(NHSA)は、最新の国家償還医薬品リスト(NRDL)にロキサデュスタットを含めた。ロキサデュスタットという薬剤は、CKD(慢性腎臓病)における貧血の治療薬としてNRDLに含まれています。このような有利な償還政策は、予測期間中に市場の成長を加速させる可能性があります。

腎臓病の有利な地域市場


市場に関する洞察

腎臓病につながる慢性疾患の有病率の高さ

慢性腎臓病 (CKD) は、世界中で 10 人に 1 人が罹患する、一般的かつ生命を脅かす病気です。 2015年から2017年にかけて、腎不全症例の75%の2つの主な原因は高血圧と糖尿病でした。さらに、2020年に国立腎臓財団が発表した研究によると、20歳以上の糖尿病人口の約35.0%が慢性腎不全を発症する可能性があります。一定期間にわたる腎臓病。

National Kidney Foundation Inc. が発表したデータによると、2020 年には CKD による死亡者数が前立腺がんや乳がんよりも多くなる可能性があります。これは人々の間で緊急の健康状態としてあまり認識されていません。アメリカの成人の 3 人に 1 人 (約 8,000 万人) が CKD のリスクにさらされています。

米国疾病管理予防センター (CDC) の推定によると、 2020 年には、糖尿病の成人の 3 人に 1 人、高血圧の成人の 5 人に 1 人が慢性腎臓病を患っている可能性があります。米国糖尿病協会によると、2015 年には米国で 3,030 万人が糖尿病を患っていました。 CDC によると、2014 年には米国で約 11 万 8,000 人が末期腎疾患の治療を開始しており、より多くの人がこの病気について認識するようになり、この治療を受ける人の数は増加すると予想されます。さらに、CDCは、腎障害のある人の約96%は慢性腎臓病であることに気づいていないと述べており、これは腎臓病市場における潜在的な市場の見通しを示しています。これらの要因は、予測期間中の市場の成長を促進すると予想されます。


製品タイプの洞察

製品タイプに基づいて、腎臓病市場は診断と治療に分割されます。 2019年には、診断セグメントが市場で最大のシェアを占めました。このセグメントの成長は、血液検査、尿検査、およびさまざまな画像検査の増加によるものと考えられます。

製品別の世界の腎臓病市場– 2019 年と 2027 年


エンド ユーザー インサイト

エンド ユーザーに基づく世界の腎臓病市場病院、診断研究所、その他に分類されます。 2019 年には病院部門が市場で大きなシェアを占めており、同部門は予測期間中に市場で最高の CAGR を記録すると予想されています。

戦略的洞察

製品の発売と承認は、増大する消費者の需要に対応するために企業が世界的な拠点と製品ポートフォリオを拡大するために一般的に採用される戦略です。腎臓病市場参加者は、世界中の顧客ベースを拡大するためにコラボレーション戦略を採用しており、これによりブランド名を世界的に維持することも可能になります。

腎臓病市場–製品タイプ別

  •      診断
    •    血液検査
    •    尿検査
    •    画像検査
    •    その他
  •  治療
    •  薬物クラス
      •   ACE 阻害剤
      •  アンジオテンシン II 受容体遮断薬
      •  利尿薬
      •  その他

腎臓病市場–エンドユーザーによる

  •      病院
  •      診断研究所
  •      その他

腎臓病市場 –地理別

  • 北アメリカ
    • 米国
    • カナダ
    • メキシコ
  • < li>ヨーロッパ
    • フランス
    • ドイツ
    • イタリア
    • イギリス
    • スペイン
    • 残りヨーロッパ
  • アジア太平洋 (APAC)
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア
    • その他のアジア太平洋地域
  • 中東およびアフリカ (MEA)
      < li>南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 中東およびアフリカのその他の地域
  • 中南米
    • ブラジル
    • アルゼンチン
    • 南米のその他の地域

  ;

会社概要

  • アボット
  • F.ホフマン・ラ・ロッシュ株式会社
  • アッヴィズ株式会社
  • ファイザー株式会社
  • テバ・ファーマシューティカル・インダストリーズ株式会社
  • グラクソ・スミスクライン plc
  • >
  • アムジェン株式会社
  • シスメックス株式会社
  • フレゼニウス メディカル ケア SE & Co. KGaA
  • シーメンス ヘルスニアーズ AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is kidney disease?

Renal disease, commonly known as chronic kidney failure, is characterised by a progressive loss of kidney function. Wastes and excess fluids are removed from the circulation by the kidneys, which are then excreted in urine. Advanced chronic renal disease can result in harmful accumulations of fluid, electrolytes, and wastes in the body. These issues may develop gradually over a lengthy period of time. Diabetes, high blood pressure, and other illnesses can lead to chronic kidney disease. Early detection and treatment can typically prevent the progression of chronic renal disease. When kidney disease continues, it can lead to renal failure, which necessitates dialysis or a kidney transplant. Chronic renal disease treatment focuses on delaying the progression of kidney damage, usually by addressing the underlying cause. Controlling the cause, however, may not be enough to prevent kidney disease from developing. Without mechanical filtering (dialysis) or a kidney transplant, chronic kidney disease can proceed to end-stage kidney failure, which is fatal.

What are the driving factors for the kidney diseases market across the globe?

Key factors that are driving the growth of this market are high prevalence of chronic diseases leading to kidney diseases and favorable reimbursement policy for kidney disease treatments are expected to boost the market growth for the kidney diseases over the years.

What is the market CAGR value of kidney diseases market during forecast period?

The CAGR value of the kidney diseases market during the forecasted period of 2020-2027 is 6.5%.

Which product type led the kidney diseases market?

The diagnosis segment held the largest share of the market in the global kidney diseases market and held the largest market share of 56.80% in 2019.

Which end user held the largest share in the kidney diseases market?

The hospitals segment dominated the global kidney diseases market and held the largest market share of 47.35% in 2019.

Who are the key players in the kidney diseases market?

The kidney diseases market majorly consists of the players such as Abbott, Siemens AG, Amgen Inc., Sysmex Corporation, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd, Fresenius Medical Care, F. Hoffmann-La Roche Ltd, AbbVie Inc., and Pfizer among others.

The List of Companies - Kidney Disease Market

  1. Abbott
  2. F. Hoffmann-La Roche Ltd.
  3. AbbVie's Inc.
  4. Pfizer Inc.
  5. Teva Pharmaceutical Industries Ltd.
  6. GlaxoSmithKline plc
  7. Amgen Inc.
  8. Sysmex Corp.
  9. Fresenius Medical Care SE & Co. KGaA
  10. Siemens Healthineers AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports